Stock listing

1779 Stock Price, News, Filings & Events — Longbio Pharma (suzhou) Co., Ltd. Class H

Selected listing: 1779 · HKEX · HKD · HK

This page tracks Longbio Pharma (suzhou) Co., Ltd. Class H's 1779:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 1779:HKEX. 1779:HKEX is the stock-level entry point for investors researching Longbio Pharma (suzhou) Co., Ltd. Class H, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Longbio Pharma (Suzhou) Co., Ltd. Class H, trading under the ticker 1779 on the Hong Kong market, has a market capitalization of approximately HKD 876.77 million. The company focuses on the development and commercialization of innovative pharmaceutical products. Longbio Pharma aims to address unmet medical needs through its research and development efforts.

1779:HKEXHKDHKUpdated September 12, 2026
Ticker
1779:HKEX
Asset type
Stock
Market cap
$1.03B
Sector
Health Technology
Industry
Biotechnology
Exchange
HKEX
Currency
HKD

Longbio Pharma (suzhou) Co., Ltd. Class H 1779:HKEX stock context

This page tracks Longbio Pharma (suzhou) Co., Ltd. Class H's 1779:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 1779:HKEX. 1779:HKEX is the stock-level entry point for investors researching Longbio Pharma (suzhou) Co., Ltd. Class H, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Longbio Pharma (Suzhou) Co., Ltd. Class H, trading under the ticker 1779 on the Hong Kong market, has a market capitalization of approximately HKD 876.77 million. The company focuses on the development and commercialization of innovative pharmaceutical products. Longbio Pharma aims to address unmet medical needs through its research and development efforts.

Latest news from Longbio Pharma (suzhou) Co., Ltd. Class H

All Longbio Pharma (suzhou) Co., Ltd. Class H news →

Research Longbio Pharma (suzhou) Co., Ltd. Class H